IN VIVO SCREENING METHOD OF THERAPEUTIC AGENT FOR MEMORY/LEARNING DYSFUNCTIONS BY SCHIZOPHRENIA
- 专利权人:
- 发明人:
- Takeo ISHIYAMA
- 申请号：
- US14460316
- 公开号：
- US20140356292A1
- 申请日:
- 2014.08.14
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- A method of evaluating memory/learning functions with the use of a model with glutamic acid N-methyl-D-aspartate (NMDA) type receptor hypofunction as an animal model for schizophrenia and with the use of reference memory task, wherein there has been found concrete means for detecting any differences in activity between typical anti-psychosis drugs and atypical anti-psychosis drugs is found.An in vivo animal model for screening of a therapeutic agent for improving cognitive dysfunction by schizophrenia is provided.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
- Beverage for antioxidative activations and improving memory comprising Lepidium meyenii extracts and Preparation method thereof
- Extract of Eucommiae ulmoides for preventing or treating of learning or memory disorder, or dementia
- Distylium recemosum extracts for the improvement of memory and cognition ability, prevention delay or treatment of Alzheimer's disease, Pharmaceutical composition containing the extracts, Functional health supplementary food containing the extracts and Method of preparing the extracts
- Platycarya strobilacea extracts for the improvement of memory and cognition ability, prevention, delay or treatment of Alzheimer's disease, Pharmaceutical composition containing the extracts, Supplementary Food containing the extracts and Method of preparing the extracts
